VIT Human Pre-designed siRNA Set A contains three designed siRNAs for VIT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Vitamin K1 2,3-epoxide is an inactive metabolite form of Vitamin K1 (HY-N0684), which is reduced to active vitamin by microsomal epoxide reductase in the vitamin K epoxide cycle. Vitamin K1 2,3-epoxide is involved in blood clotting[1].

VKORC1 Human Pre-designed siRNA Set A contains three designed siRNAs for VKORC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VKORC1L1 Human Pre-designed siRNA Set A contains three designed siRNAs for VKORC1L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VLDLR Human Pre-designed siRNA Set A contains three designed siRNAs for VLDLR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VMA21 Human Pre-designed siRNA Set A contains three designed siRNAs for VMA21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VMAC Human Pre-designed siRNA Set A contains three designed siRNAs for VMAC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VMAT2-IN-3 (compound 10) is a potent vesicular monoamine transporter-2 (VMAT2) inhibitor with a Ki of 0.71 nM. VMAT2-IN-3 has the potential for neurological or psychiatric disease research[1].

VMO1 Human Pre-designed siRNA Set A contains three designed siRNAs for VMO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VMP1 Human Pre-designed siRNA Set A contains three designed siRNAs for VMP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VNN1 Human Pre-designed siRNA Set A contains three designed siRNAs for VNN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VNN2 Human Pre-designed siRNA Set A contains three designed siRNAs for VNN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Volvalerenal E is an active product that can be isolated from a chloroform extract of the roots of Valeriana officinalis var. latifolia.[1].

VOPP1 Human Pre-designed siRNA Set A contains three designed siRNAs for VOPP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Vorapaxar-d5 is deuterated labeled Vorapaxar (HY-10119). Vorapaxar (SCH 530348), an antiplatelet agent, is a selective, orally active, and competitive thrombin receptor protease-activated receptor (PAR-1) antagonist (Ki=8.1 nM). Vorapaxar (SCH 530348) inhibits thrombin receptor-activating peptide (TRAP)-induced platelet aggregation in a dose-dependent manner[1].

Voriconazole (Standard) is the analytical standard of Voriconazole. This product is intended for research and analytical applications. Voriconazole (UK-109496) is a second-generation, broad-spectrum triazole antifungal agent that inhibits fungal ergosterol biosynthesis. Voriconazole exerts its antifungal activity by inhibition of 14-α-lanosterol demethylation, which is mediated by fungal cytochrome P450 enzymes[1][2].

Voxelotor-d7 is the deuterium labeled Voxelotor (HY-18681). Voxelotor is a potent inhibitor of haemoglobin S (HbS) polymerization[1].

VPREB1 Human Pre-designed siRNA Set A contains three designed siRNAs for VPREB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPREB3 Human Pre-designed siRNA Set A contains three designed siRNAs for VPREB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS11 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS13A Human Pre-designed siRNA Set A contains three designed siRNAs for VPS13A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS13B Human Pre-designed siRNA Set A contains three designed siRNAs for VPS13B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS13C Human Pre-designed siRNA Set A contains three designed siRNAs for VPS13C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS13D Human Pre-designed siRNA Set A contains three designed siRNAs for VPS13D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS16 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS18 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS25 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS25 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS26A Human Pre-designed siRNA Set A contains three designed siRNAs for VPS26A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS26B Human Pre-designed siRNA Set A contains three designed siRNAs for VPS26B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS28 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS28 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS29 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS29 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS33A Human Pre-designed siRNA Set A contains three designed siRNAs for VPS33A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS33B Human Pre-designed siRNA Set A contains three designed siRNAs for VPS33B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS35 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS35 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS35L Human Pre-designed siRNA Set A contains three designed siRNAs for VPS35L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS36 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS36 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS37A Human Pre-designed siRNA Set A contains three designed siRNAs for VPS37A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS37B Human Pre-designed siRNA Set A contains three designed siRNAs for VPS37B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS39 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS39 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS41 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS41 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.